Skip to content

Comparative Study of 2 Anti-Dandruff shampoos, in patients with dandruff.

A two-arm prospective, randomized, double blind, active controlled comparative study of 2 Anti-Dandruff shampoos, in patients with dandruff or seborrheic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035042
Enrollment
90
Registered
2021-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L21- Seborrheic dermatitis

Interventions

Intervention1: Luliconazole (1% w/v), Salicylic Acid (3% w/v) shampoo, Zinc pyrithione: Approximately 5 ml of shampoo and massage on the wet scalp. Leave it on for 5 minutes after which rinse with wat

Sponsors

Lupin Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: With clinical diagnosis of Dandruff or seborrheic dermatitis of the scalp.

Exclusion criteria

Exclusion criteria: Pregnancy by UPT or Lactating women History or presence of compromising dermatosis elsewhere on the skin Actinically damaged skin Have used an antidandruff agent in the past 14 days

Design outcomes

Primary

MeasureTime frame
Change in degree of scaling using a 4-point scaleTimepoint: Baseline, week 4 and week 12

Secondary

MeasureTime frame
Change in degree of erythema using a 4-point scaleTimepoint: Baseline, week 4 and week 12;Change in degree of scalp itching using a 4-point scaleTimepoint: Baseline, week 4 and week 12;Clinical Examination of Scalp condition for in use tolerance with respect to drynessTimepoint: week 4 and week 12;Proportions of patients reporting recurrenceTimepoint: week 12;Subjective self-assessment questionnaire to assess participant perception of the in-use tolerance of productsTimepoint: week 4 and week 12;Subjective self-assessment questionnaire to assess patient perception of the efficacy of productsTimepoint: week 4 and week 12

Countries

India

Contacts

Public ContactDr Dipesh Sonawane

Lupin Ltd.

dipeshsonawane@lupin.com07071570717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026